Highly purified HMG versus recombinant FSH for ovarian stimulation in IVF cycles

By Platteau Peter   Nyboe Andersen Anders   Loft Anne   Smitz Johan   Danglas Pascal   Devroey Paul  

Reproductive BioMedicine Online, Vol. 17, Iss. 2, 2008-08 ,pp. : 190-198

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Outcome of cryopreserved pronuclear oocytes obtained after ovarian stimulation with either HMG or recFSH and the GnRH-antagonist cetrorelix

By Asimakopoulos Byron   Nikolettos Nikos   Al-Hasani Safaa  

Reproductive BioMedicine Online, Vol. 5, Iss. 3, 2002-11 ,pp. : 52-56

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Ovarian responses to recombinant FSH or HMG in normogonadotrophic women following pituitary desensitization by a depot GnRH agonist for assisted reproduction

By Balasch Juan   Peñarrubia Joana   Fábregues Francisco   Vidal Ester   Casamitjana Roser   Manau Dolors   Carmona Francisco   Creus Montserrat   Vanrell Juan A  

Reproductive BioMedicine Online, Vol. 7, Iss. 1, 2003-07 ,pp. : 35-42

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Recombinant LH supplementation to recombinant FSH during induced ovarian stimulation in the GnRH-antagonist protocol: a meta-analysis

By Baruffi RLR   Mauri AL   Petersen CG   Felipe V   Martins AMC   Cornicelli J   Cavagna M   Oliveira JBA   Franco JG  

Reproductive BioMedicine Online, Vol. 14, Iss. 1, 2007-01 ,pp. : 14-25

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Administration of recombinant human FSH (solution in cartridge) with a pen device in women undergoing ovarian stimulation

By Pang S   Kaplan B   Karande V   Westphal LM   Scott R   Givens C   Sacks P    

Reproductive BioMedicine Online, Vol. 7, Iss. 3, 2003-10 ,pp. : 319-326

Reproductive Healthcare Ltd

Access to resources Recommend Favorite